ARScience Biotherapeutics Initiates Technology Transfer for Commercial Manufacturing of Low Dose Interleukin-2
July 22, 2026

July 22, 2026
June 16, 2026
June 8, 2026
May 19, 2026
May 19, 2026
May 7, 2026
April 17, 2026
April 2, 2026
March 19, 2026
July 22, 2026
Milestone marks the transition of Low Dose IL-2 from clinical development to a scalable, regulatory-ready commercial manufacturing process Strategic s...
July 20, 2026
New registration expands access to minimally invasive skin microbiopsy for clinical, research, and wellness applications. Trajan today announced the H...
July 15, 2026
Consortium initially brings together Lunit, Mindpeak, Imagene AI, Dipath AI, Nucleai, Tivenix and Indica Labs to give biopharma sponsors a single CRO-...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225